MEHMET OKCU to Drug Costs
This is a "connection" page, showing publications MEHMET OKCU has written about Drug Costs.
Connection Strength
0.174
-
Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2022 Jan 15; 128(2):317-325.
Score: 0.174